What is the clinical evidence from this study?

Study design: Cohort. Population: Cardiac myxoma (n=74). Intervention: Surgical resection. Primary outcome: Tumor recurrence and hospital mortality.

January 1, 2006Yonsei Medical JournalOpen Access

Clinical Experiences of Cardiac Myxoma

View Full Paper

Ask AI

Bookmark

Key result

Surgical resection of cardiac myxoma resulted in no hospital deaths and no tumor recurrence during a mean follow-up of 105.7 months.

Population

74 patients with cardiac myxoma surgically treated at a single center, mean age 50.4 years, 71.6% female…

Design

Case_series

Follow-up

mean 105.7 +/- 73.6 months

Authors

SYSong-Hyeon YuYonsei University SLSang‐Hyun LimAjou University YHYou-Sun HongYonsei University

Discussion

Member takes

Implication

Affirms low risk with resection in this series; leaves open generalizability beyond small case reports.

Study Design

Type

Cohort (n=74)

Multicenter

Structured PICO

Population

74 patients with cardiac myxoma who underwent surgical resection were retrospectively reviewed over a mean follow-up of 105.7 months.

Intervention

Surgical resection of cardiac myxoma via median sternotomy under moderate hypothermia and an arrested heart with cardiopulmonary bypass.

Outcome

Tumor recurrence and mortality (early and late) during follow-up.hard clinical

Surgical resection of cardiac myxoma is a safe and curative treatment, with no tumor recurrence observed after complete resection during long-term follow-up.

Limitations

Retrospective study design

Cite This Study

Yu et al. (2006) conducted a cohort in Cardiac myxoma (n=74). Surgical resection was evaluated on Tumor recurrence and hospital mortality. Surgical resection of cardiac myxoma resulted in no hospital deaths and no tumor recurrence during a mean follow-up of 105.7 months.

synapsesocial.com/papers/6a9e96759e5851e83bda2964 https://doi.org/10.3349/ymj.2006.47.3.367

View Full Paper

Ask AI

Bookmark

January 1, 2006Yonsei Medical JournalOpen Access

Clinical Experiences of Cardiac Myxoma

View Full Paper

Ask AI

Bookmark

Key result

Surgical resection of cardiac myxoma resulted in no hospital deaths and no tumor recurrence during a mean follow-up of 105.7 months.

Population

74 patients with cardiac myxoma surgically treated at a single center, mean age 50.4 years, 71.6% female…

Design

Case_series

Follow-up

mean 105.7 +/- 73.6 months

Authors

SYSong-Hyeon YuYonsei University SLSang‐Hyun LimAjou University YHYou-Sun HongYonsei University

Discussion

Member takes

Implication

Affirms low risk with resection in this series; leaves open generalizability beyond small case reports.

Study Design

Type

Cohort (n=74)

Multicenter

Structured PICO

Population

74 patients with cardiac myxoma who underwent surgical resection were retrospectively reviewed over a mean follow-up of 105.7 months.

Intervention

Surgical resection of cardiac myxoma via median sternotomy under moderate hypothermia and an arrested heart with cardiopulmonary bypass.

Outcome

Tumor recurrence and mortality (early and late) during follow-up.hard clinical

Surgical resection of cardiac myxoma is a safe and curative treatment, with no tumor recurrence observed after complete resection during long-term follow-up.

Limitations

Retrospective study design

Cite This Study

synapsesocial.com/papers/6a9e96759e5851e83bda2964 https://doi.org/10.3349/ymj.2006.47.3.367

Also Consider

Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context:

View Full Paper

Ask AI

Bookmark